Clin2
NCT07010445Likely a fitRecruiting

Gut-brain connection in resistant epilepsy

Gut MicrobiotaEpilepsyDrug-Resistant Epilepsy

Part of Brain & nervous system clinical trials.

This study looks at how the gut and brain talk to each other in people with epilepsy, especially when seizures are hard to control. It may help find new ways to treat epilepsy by focusing on the gut.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
3 years to 50 years
Study type
Interventional

Who can take part

  • You are between 3 and 50 years old.
  • You have epilepsy (either newly diagnosed or drug-resistant).
  • You or a caregiver can take part and sign a consent form.
  • You do not have a chronic inflammatory bowel disease (like Crohn's or ulcerative colitis).
  • You are not on a special diet (like keto or gluten-free).
  • You have not taken antibiotics, steroids, or probiotics in the past month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06210022Recruiting
Cognitive problems in drug-resistant vs drug-responsive epilepsy

This study compares thinking skills in people with focal epilepsy that responds well to medication versus epilepsy that doesn't. It aims to understand how different types of epilepsy affect memory, attention, and other cognitive functions.

Milan
NCT05335187Recruiting
Electrode test during epilepsy surgery planning

This study tests a new “hybrid” type of electrodes placed inside the brain to better map where seizures start in people with difficult (drug-resistant) focal epilepsy. It may help doctors plan safer and more effective surgery, though it involves an invasive brain monitoring procedure.

Bern, Canton of Bern
NCT07253701Recruiting
Epilepsy and gut bacteria: understanding treatment response

This study looks at how the bacteria in your gut relate to how well epilepsy treatments work. It compares people with newly diagnosed epilepsy (who haven't yet started medicine) to healthy people without epilepsy.

Gothenburg
NCT06665880Not yet recruiting
Genes and proteins in hard-to-treat epilepsy patients

This study looks at genes, proteins, and other body chemicals in people with drug-resistant epilepsy (seizures that continue despite trying multiple medications). By studying samples from people who are already having SEEG surgery to find where seizures start, researchers hope to discover new clues about what makes epilepsy hard to treat. The results may help develop better tests or treatments in the future.

Beijing
NCT03268824Recruiting
Brain imaging study in drug-resistant focal epilepsy

This study uses MRI brain scans to see how “epileptic discharges” may affect brain connections in the developing brain. It also scans comparison participants without drug-resistant focal epilepsy to help researchers understand what is different.

Paris
NCT07023744Not yet recruiting· Phase 2
Cannabis-based medicine for hard-to-treat seizures

This study tests whether a cannabis-based medicine can reduce seizures in people with epilepsy that hasn't improved with other treatments. It may offer a new option for those who continue to have seizures.

Hear when a new Gut Microbiota trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.